Latest Breaking News On - Department of lymphoma myeloma - Page 1 : comparemela.com

Dr Neelapu on Streamlining the Delivery of CAR T-Cell Therapy in Lymphoma

Sattva S. Neelapu, MD, discusses processes that have been adopted to streamline the delivery of CAR T-cell therapy to patients with lymphoma.

Dr Neelapu on Addressing CAR T-Cell Resistance in Lymphoma

Sattva S. Neelapu, MD, discusses mechanisms of resistance to CAR T-cell therapies in lymphoma and how these areas of need may be addressed.

Neelapu Highlights the Nuances of CAR T-Cell Therapy Administration in Lymphoma

CAR T-Cell Agents Offer Efficacy in Lymphoma, But Additional Approaches Are Needed to Overcome Resistance

Dr Lee on the Rationale for Investigating Linvoseltamab in R/R Multiple Myeloma

Hans Lee, MD, discusses the rationale for the phase 1/2 LINKER-MM1 trial of linvoseltamab in patients with relapsed/refractory multiple myeloma.